WallStreetZenWallStreetZen

NASDAQ: OPT
Opthea Ltd Stock

Overview
ForecastEarningsDividendOwnership
$3.40+0.00 (+0%)
Updated Apr 18, 2024
OPT Price
$3.40
Fair Value Price
$0.96
Market Cap
$198.54M
52 Week Low
$1.60
52 Week High
$4.42
P/E
-1.32x
P/B
-33.92x
P/S
319.91x
PEG
N/A
Dividend Yield
N/A
Revenue
$385.28k
Earnings
-$142.52M
Gross Margin
100%
Operating Margin
-35,036.08%
Profit Margin
-36,992%
Debt to Equity
-17.85
Operating Cash Flow
-$121M
Beta
0.29
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

OPT Overview

Opthea Limited is develing therapies that treat highly prevalent and progressive retinal eye diseases (wet age-related macular degeneration and diabetic macular edema). Its lead product candidate, OPT-302 has the potential to address the unmet medical need of wet AMD and DME patients. Opthea was incorporated in 1984 and is headquartered in South Yarra, Australia.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OPT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OPT ($3.40) is overvalued by 253.92% relative to our estimate of its Fair Value price of $0.96 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
OPT ($3.40) is not significantly undervalued (253.92%) relative to our estimate of its Fair Value price of $0.96 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
OPT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more OPT due diligence checks available for Premium users.

Be the first to know about important OPT news, forecast changes, insider trades & much more!

OPT News

Valuation

OPT fair value

Fair Value of OPT stock based on Discounted Cash Flow (DCF)
Price
$3.40
Fair Value
$0.96
Overvalued by
253.92%
OPT ($3.40) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
OPT ($3.40) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
OPT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

OPT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.32x
Industry
15.68x
Market
41.33x

OPT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-33.92x
Industry
5.76x

OPT's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
OPT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
OPT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$98.6M
Liabilities
$104.5M
Debt to equity
-17.85
OPT's short-term assets ($98.39M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OPT's short-term assets ($98.39M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OPT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OPT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
OPT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

OPT vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
OPT$198.54M0.00%-1.32x-33.92x
CDXS$196.85M+1.45%-2.50x2.27x
ATNM$196.07M-8.00%-3.64x5.39x
XFOR$201.53M+0.42%-2.11x3.94x
ZVRA$195.42M-3.02%-3.46x3.16x
View Top Biotech Stocks

Opthea Stock FAQ

What is Opthea's quote symbol?

(NASDAQ: OPT) Opthea trades on the NASDAQ under the ticker symbol OPT. Opthea stock quotes can also be displayed as NASDAQ: OPT.

If you're new to stock investing, here's how to buy Opthea stock.

What is the 52 week high and low for Opthea (NASDAQ: OPT)?

(NASDAQ: OPT) Opthea's 52-week high was $4.42, and its 52-week low was $1.60. It is currently -23.08% from its 52-week high and 112.5% from its 52-week low.

How much is Opthea stock worth today?

(NASDAQ: OPT) Opthea currently has 467,159,374 outstanding shares. With Opthea stock trading at $3.40 per share, the total value of Opthea stock (market capitalization) is $198.54M.

Opthea stock was originally listed at a price of $12.30 in Oct 16, 2020. If you had invested in Opthea stock at $12.30, your return over the last 3 years would have been -72.36%, for an annualized return of -34.86% (not including any dividends or dividend reinvestments).

How much is Opthea's stock price per share?

(NASDAQ: OPT) Opthea stock price per share is $3.40 today (as of Apr 18, 2024).

What is Opthea's Market Cap?

(NASDAQ: OPT) Opthea's market cap is $198.54M, as of Apr 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Opthea's market cap is calculated by multiplying OPT's current stock price of $3.40 by OPT's total outstanding shares of 467,159,374.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.